ALFA Finder| Metric | H2 FY26 | H1 FY26 | H2 FY25 |
|---|---|---|---|
| Revenue from operations | 131.6 | 109.2 | 110.8 |
| Other income | 1.5 | 1.4 | 1.2 |
| Total income | 133.1 | 110.6 | 112.0 |
| Profit before exceptional items & tax | 2.7 | 1.5 | 1.3 |
| Profit before tax | 2.7 | 1.5 | 1.3 |
| Net profit | 1.1 | 0.2 | 0.9 |
| Operating margin | 2.0% | 1.4% | 1.2% |
A dash means the filing did not report that period; n/m means not meaningful (margin on near-zero revenue). Growth is not shown when either period was a loss. Operating profit excludes other income.
| Net profit, year on year | +22.20% |
|---|---|
| Net profit, quarter on quarter | +450.00% |
| Revenue, year on year | +18.80% |
NSE results filing, NSE: AMBANIORGO. Figures extracted from the filing.
Ambani Orgochem Ltd: key numbers
- Share price
- ₹180.65
- Market cap
- ₹136.2 Cr
- Revenue (annual)
- ₹240.7 Cr
- Net profit (annual)
- ₹1.33 Cr
- P/E (TTM)
- 102.1×Sector 35.5×
- Promoter holding
- 52.59%
- FII holding
- 0.00%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Ambani Orgochem Ltd
All →Ambani Orgochem Credit Rating
Infomerics upgraded Ambani Orgochem's bank loan ratings to IVR BBB-/Stable and removed them from Issuer Not Cooperating. The action reflects improved financial risk profile.
Ambani Orgochem Earnings Call Transcript: Key Takeaways
H1 FY27 consolidated revenue +54.87% to ₹171.22 Cr; PAT ₹3.45 Cr from ₹0.19 Cr. EBITDA +43% but margin slipped; management gives no numeric guidance.
Ambani Orgochem Management Change
Ambani Orgochem announced the resignation of non-executive non-independent director Bhavin Patel, effective 29 October 2026. The resignation was attributed to professional priorities and commitments.
Ambani Orgochem Convertible Warrants
Ambani Orgochem members approved a Rs 43.93 Crore preferential warrant issue and capital changes. Promoters receive 30.1 lakh of the 43.93 lakh warrants.
- Value
- ₹43.93 Cr
Ambani Orgochem Investor Presentation: Key Takeaways
H1 FY27 consolidated: revenue ₹171.22 cr (+54.87%), EBITDA ₹11.32 cr (+43.00%), PAT ₹3.45 cr vs ₹0.19 cr. Strategy: capacity expansion and downstream specialty chemicals.
Ambani Orgochem Annual General Meeting
Ambani Orgochem's 1st EGM on 26 October 2026 took up four special resolutions. Items cover authorised capital, the capital clause, and preferential warrants.